Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Down 47.6% in July

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 1,153 shares, a drop of 47.6% from the July 15th total of 2,202 shares. Based on an average daily trading volume, of 16,349 shares, the short-interest ratio is currently 0.1 days.

Revolution Medicines Trading Up 4.5%

Shares of NASDAQ:RVMDW traded up $0.55 on Tuesday, hitting $12.59. 20,295 shares of the company were exchanged, compared to its average volume of 115,872. Revolution Medicines has a 1-year low of $0.16 and a 1-year high of $12.62. The stock’s 50 day moving average price is $8.92 and its 200 day moving average price is $5.28.

About Revolution Medicines

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.